| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Jul―11 |
The SARS-CoV-2 envelope PDZ binding motif acts as a virulence factor disrupting host’s epithelial cell-cell junctions |
Flavio Alvarez, Guilherme Dias de Melo, Florence Larrous, Lauriane Kergoat, Batiste Boëda, Vincent Michel, et al. (+8) Danielle Seilhean, Magali Tichit, David Hing, David Hardy, Etienne Kornobis, Hervé Bourhy, Nicolas Wolff, Célia Caillet-Saguy |
| 2 |
[GO] |
2024―Nov―08 |
The role of reactive oxygen species in severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection-induced cell death |
Jiufeng Xie, Cui Yuan, Sen Yang, Zhenling Ma, Wenqing Li, Lin Mao, et al. (+2) Pengtao Jiao, Wei Liu |
| 3 |
[GO] |
2024―Jul―19 |
Monitoring correlates of SARS-CoV-2 infection in cell culture using a two-photon-active calcium-sensitive dye |
Domokos Máthé, Gergely Szalay, Levente Cseri, Zoltán Kis, Bernadett Pályi, Gábor Földes, et al. (+11) Noémi Kovács, Anna Fülöp, Áron Szepesi, Polett Hajdrik, Attila Csomos, Ákos Zsembery, Kristóf Kádár, Gergely Katona, Zoltán Mucsi, Balázs József Rózsa, Ervin Kovács |
| 4 |
[GO] |
2022―Jul―30 |
Comprehensive overview of COVID-19-related respiratory failure: focus on cellular interactions |
Fahimeh Zamani Rarani, Mohammad Zamani Rarani, Michael R. Hamblin, Bahman Rashidi, Seyed Mohammad Reza Hashemian, Hamed Mirzaei |
| 5 |
[GO] |
2022―Jun―17 |
SARS-CoV-2: phenotype, genotype, and characterization of different variants |
Mohammadreza Saberiyan, Elham Karimi, Zahra Khademi, Parvaneh Movahhed, Amir Safi, Ameneh Mehri-Ghahfarrokhi |
| 6 |
[GO] |
2022―May―31 |
COVID-19 therapies: do we see substantial progress? |
Lucyna Matusewicz, Marlena Golec, Aleksander Czogalla, Kazimierz Kuliczkowski, Adam Konka, Joanna Zembala-John, Aleksander F. Sikorski |
| 7 |
[GO] |
2022―May―13 |
An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19) |
Armina Alagheband Bahrami, Ali Azargoonjahromi, Samin Sadraei, Aryan Aarabi, Zahra Payandeh, Masoumeh Rajabibazl |
| 8 |
[GO] |
2022―Feb―02 |
The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies |
Hamidreza Zalpoor, Abdullatif Akbari, Azam Samei, Razieh Forghaniesfidvajani, Monireh Kamali, Azadeh Afzalnia, et al. (+6) Shirin Manshouri, Fatemeh Heidari, Majid Pornour, Majid Khoshmirsafa, Hossein Aazami, Farhad Seif |
| 9 |
[GO] |
2022―Jan―11 |
The probable role and therapeutic potential of the PI3K/AKT signaling pathway in SARS-CoV-2 induced coagulopathy |
Mohammad Rafi Khezri, Reza Varzandeh, Morteza Ghasemnejad-Berenji |
|
